Vasoprotective and cardioprotective antidiabetic therapy
AssigneeBoehringer Ingelheim International GmbH
InventorsThomas Klein, Andreas Daiber, Odd-Eric Johansen, Michael Mark, Sanjaykumar Patel, Hans-Juergen Woerle
Life of this patent
Estimating the term…
Abstract
The present invention relates to certain DPP-4 inhibitors for treating and/or preventing oxidative stress, vascular stress and/or endothelial dysfunction as well as to the use of such DPP-4 inhibitors in treatment and/or prevention of diabetic or non-diabetic patients, including patient groups at risk of cardiovascular and/or renal disease.
Claims5
A method for treating oxidative stress, vascular stress and/or endothelial dysfunction in a sepsis patient in need thereof, the method comprising administering linagliptin to the patient.
A method for treating sepsis comprising administering linagliptin to a patient in need thereof.
Dependencies are inferred from the claim text.